Table 3.
Class | Risk | Description | Route |
---|---|---|---|
I | Low risk | Non-invasive, does not interact with body | Self-declaration route outlines in Annex VII Module. An EU Declaration of Conformity—manufacturer must declare the device satisfies the provisions of the directive. |
IIa | Medium | Generally invasive Therapeutic transfer of energy to patient or used for the diagnosis or monitoring of medical condition |
Carry out conformity assessment carried out by NB using Annex II, IV, V, or VI. Can declare conformity with the provisions of directives and regulations (Annex VII). |
IIb | Medium | Invasive—surgical or implantation Potential to modify body fluid |
Full quality assurance (Annex II)—with assessment by NB of technical documents in one sample in accordance with the directive (Annex II, Section 7). |
III | High | Invasive—used to sustain human life, essential to maintain human health Devices connected to CNS or CCS |
Full quality assurance system audit (Annex II)—full examination of device by a Notified Body (NB) |